跳至主要内容
临床试验/NCT05075330
NCT05075330已完成不适用

SMART Trial: Reducing Stigma Towards Opioid Use Disorder at the Community Level

Karen Derefinko, PhD2 个研究点 分布在 1 个国家目标入组 199 人开始时间: 2021年6月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
199
试验地点
2
主要终点
Stigma score

研究概览

简要总结

The goal of this project is to engage community members from two low-income African American communities (N=200) in a survey study that assesses stigma toward those with Opioid Use Disorder (OUD). Those from the intervention community will be subject to a stigma reduction campaign via billboards. Those from the control community will not. Stigma will be re-assessed following the period of the campaign.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Identify as African American or Mixed race
  • Reside in Frayser or Orange Mound Communities
  • Access to telephone for follow-up assessment

排除标准

  • Unable to understand consent procedures

结局指标

主要结局

Stigma score

时间窗: Change from baseline stigma score at 8 weeks

Pre- and post-intervention stigma assessments using the Exposure to Drug Users Index, Drug Use Stigmatization Scale, and the Stigma of Drug Users Scale

次要结局

未报告次要终点

研究者

发起方
Karen Derefinko, PhD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Karen Derefinko, PhD

Associate Professor

University of Tennessee

研究点 (2)

Loading locations...

相似试验

SMART Trial: Community Stigma Reduction | 临床试验